CoChat
Sign Up
Cited by 60

The DOI matches its Crossref record; 16 of the 16 references it cites were found in a registry or an index.

Long-term non-pharmacological weight loss interventions for adults with prediabetes

Norris, Susan L, Zhang, Xuanping, Avenell, Alison, Gregg, Edward, Schmid, Christopher H, Lau, Joseph·2005·Cochrane Database of Systematic Reviews
DOI 10.1002/14651858.cd005270
Open this paper in CoChat — free account

Overview

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1002/14651858.cd005270

Cites

16 of 16 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 16 references

Research works printed but not linked: 71

  1. Diabetes Prevention Program (DPP) Research Group, 1999, The Diabetes Prevention Program: design and methods for a clinical trial in the prevention of type 2 diabetes, Diabetes Care, 22, 623, 10.2337/diacare.22.4.623 · DOI · Paper page
  2. Diabetes Prevention Program (DPP) Research Group, 2002, The Diabetes Prevention Program: recruitment methods and results, Controlled Clinical Trials, 23, 157, 10.1016/S0197-2456(01)00184-2 · DOI
  3. Dyson, 1997, The Fasting Hyperglycaemia Study II: Randomized controlled trial of reinforced healthy-living advice in subjects with increased but not diabetic fasting plasma glucose, Metabolism: Clinical and Experimental, 46, 5
  4. Eriksson, 1999, Leptin concentrations and their relation to body fat distribution and weight loss--a prospective study in individuals with impaired glucose tolerance. DPS-study group, Hormone Metabolism Research, 31, 616, 10.1055/s-2007-978807 · DOI
  5. Jarrett, 1979, Worsening to diabetes in men with impaired glucose tolerance ("borderline diabetes"), Diabetologia, 16, 25, 10.1007/BF00423146 · DOI
  6. Jarrett, 1987, Changes in blood pressure and body weight over ten years in men selected for glucose intolerance, Journal of Epidemiology and Community Health, 41, 145, 10.1136/jech.41.2.145 · DOI
  7. Li, 2002, Effects of insulin resistance and insulin secretion on the efficacy of interventions to retard development of type 2 diabetes mellitus: the DA Qing IGT and Diabetes Study, Diabetes Research and Clinical Practice, 58, 193, 10.1016/S0168-8227(02)00175-4 · DOI
  8. Liao, 2002, Improvement of BMI, body composition, and body fat distribution with lifestyle modification in Japanese Americans with impaired glucose tolerance, Diabetes Care, 25, 1504, 10.2337/diacare.25.9.1504 · DOI
  9. Lindahl, 1999, Improved fibrinolysis by intense lifestyle intervention. A randomized trial in subjects with impaired glucose tolerance, Journal of Internal Medicine, 246, 105, 10.1046/j.1365-2796.1999.00537.x · DOI
  10. Mensink, 2003, Lifestyle intervention according to general recommendations improves glucose tolerance, Obesity Research, 11, 1588, 10.1038/oby.2003.211 · DOI
  11. Mensink, 2003, Study on lifestyle-intervention and impaired glucose tolerance Maastricht (SLIM): Design and screening results, Diabetes Research and Clinical Practice, 61, 49, 10.1016/S0168-8227(03)00067-6 · DOI
  12. Mensink, 2003, Study on lifestyle intervention and impaired glucose tolerance Maastricht (SLIM): Preliminary results after one year, International Journal of Obesity and Related Metabolic Disorders, 27, 377, 10.1038/sj.ijo.0802249 · DOI
  13. Page, 1992, Can lifestyles of subjects with impaired glucose tolerance be changed? A feasibility study, Diabetic Medicine, 9, 562, 10.1111/j.1464-5491.1992.tb01839.x · DOI
  14. Pan, 1997, Effects of diet and exercise in preventing NIDDM in people with impaired glucose tolerance: The Da Qing IGT and Diabetes Study, Diabetes Care, 20, 537, 10.2337/diacare.20.4.537 · DOI · Paper page
  15. Uusitupa, 2000, The Finnish Diabetes Prevention Study, British Journal of Nutrition, 83, S137, 10.1017/S0007114500001070 · DOI
  16. Uusitupa, 2003, Long-term improvement in insulin sensitivity by changing lifestyles of people with impaired glucose tolerance; 4-year results from the Finnish Diabetes Prevention Study, Diabetes, 52, 2532, 10.2337/diabetes.52.10.2532 · DOI · Paper page
  17. Ratzmann, 1982, Effect of a combined diet-training program on the insulin sensitivity of obese persons with normal or disordered glucose tolerance, Zeitschrift fur die Gesamte Innere Medizin und Ihre Grenzgebiete, 37, 304
  18. Watanabe, 2003, Randomized controlled trial of a new dietary education program to prevent type 2 diabetes in a high risk group of Japanese male workers, Diabetes Care, 26, 3209, 10.2337/diacare.26.12.3209 · DOI
  19. American Diabetes Association, 1997, Report on the Expert Committee on the Diagnosis and Classification of Diabetes Mellitus, Diabetes Care, 20, S5
  20. American Diabetes Association, 2003, Evidence-based nutrition principles and recommendations for the treatment and prevention of diabetes and related complications, Diabetes Care, 26 (Supplement, S51, 10.2337/diacare.26.2007.S51 · DOI
  21. American Diabetes Association, 2004, Diagnosis and classification of diabetes mellitus, Diabetes Care, 27, S5, 10.2337/diacare.27.2007.S5 · DOI
  22. American Diabetes Association, 2004, Prevention or delay of type 2 diabetes, Diabetes Care, 27, S47, 10.2337/diacare.27.2007.S47 · DOI
  23. Alberti, 1998, Definition, diagnosis and classification of diabetes mellitus and its complications. Part I: diagnosis and classification of diabetes mellitus. Provisional report of a WHO consultation, Diabetic Medicine, 15, 539, 10.1002/(SICI)1096-9136(199807)15:7<539::AID-DIA668>3.0.CO;2-S · DOI
  24. Anderson, 2001, Obesity and disease management: effects of weight loss on comorbid conditions, Obesity Research, 9 (Supplement 4, 326S
  25. Benjamin, 2003, Estimated number of adults with prediabetes in the U.S. in 2000: opportunities for prevention, Diabetes Care, 26, 645, 10.2337/diacare.26.3.645 · DOI
  26. Berlin, 1997, Does blinding of readers affect the results of meta-analyses? Results of a randomized trial, Online Journal of Current Clinical Trials, Document no. 20
  27. Boule, 2001, Effects of exercise on glycemic control and body mass in type 2 diabetes mellitus: a meta-analysis of controlled clinical trials, Journal of American Medical Association, 286, 1218, 10.1001/jama.286.10.1218 · DOI · Paper page
  28. Brown, 1996, Promoting weight loss in type II diabetes, Diabetes Care, 19, 613, 10.2337/diacare.19.6.613 · DOI
  29. Chiasson, 2002, Acarbose for prevention of type 2 diabetes mellitus: the STOP-NIDDM randomised trial, Lancet, 359, 2072, 10.1016/S0140-6736(02)08905-5 · DOI · Paper page
  30. Clarke, 2001, Cochrane Reviewers Handbook, Issue 4
  31. The DECODE Study Group, 2001, Glucose tolerance and cardiovascular mortality: comparison of fasting and 2-hour diagnostic criteria, Archives of Internal Medicine, 161, 397, 10.1001/archinte.161.3.397 · DOI · Paper page
  32. DerSimonian, 1954, Meta-analysis in clinical trials, Controlled Clinical Trials, 7, 177, 10.1016/0197-2456(86)90046-2 · DOI · Paper page
  33. Edelstein, 1997, Predictors of progression from impaired glucose tolerance to NIDDM: an analysis of six prospective studies, Diabetes, 46, 701, 10.2337/diab.46.4.701 · DOI
  34. Feinstein, 1985, Clinical Epidemiology: The Architecture of Clinical Research
  35. Freeman, 2001, Pravastatin and the development of diabetes mellitus: evidence for a protective treatment effect in the West of Scotland Coronary Prevention Study, Circulation, 103, 357, 10.1161/01.CIR.103.3.357 · DOI · Paper page
  36. French, 2001, Environmental influences on eating and physical activity, Annual Reviews in Public Health, 22, 309, 10.1146/annurev.publhealth.22.1.309 · DOI
  37. Hansson, 1999, Effect of angiotensin-converting-enzyme inhibition compared with conventional therapy on cardiovascular morbidity and mortality in hypertension: The Captopril Prevention Project (CAPPP) randomised trial, Lancet, 353, 611, 10.1016/S0140-6736(98)05012-0 · DOI
  38. Higgins, 2003, Measuring inconsistency in meta-analysis, British Medical Journal, 327, 557, 10.1136/bmj.327.7414.557 · DOI · Paper page
  39. Hoaglin DC Mosteller F Tukey JW Understanding Robust and Exploratory Data Analysis 1st Edition New York John Wiley & Sons, Inc 1983
  40. Irwig, 1994, Guidelines for meta-analyses evaluating diagnostic tests, Annals of Internal Medicine, 120, 667, 10.7326/0003-4819-120-8-199404150-00008 · DOI
  41. Kanaya, 2003, Glycemic effects of postmenopausal hormone therapy: The heart and estrogen/progestin replacement study: A randomized, double-blind, placebo-controlled trial, Annals of Internal Medicine, 138, 1, 10.7326/0003-4819-138-1-200301070-00005 · DOI · Paper page
  42. Kaplan, 1987, Selective attrition causes overestimates of treatment effects in studies of weight loss, Addictive Behavior, 12, 297, 10.1016/0306-4603(87)90044-X · DOI
  43. Kelley, 2001, Effects of exercise on glucose homeostasis in type 2 diabetes mellitus, Medicine and Science in Sports and Exercise, 33 (suppl 6), S495, 10.1097/00005768-200106001-00020 · DOI
  44. Kramer, 1989, Long-term follow-up of behavioral treatment for obesity: patterns of weight regain among men and women, International Journal of Obesity, 13, 123
  45. Kuller, 2001, Womens Healthy Lifestyle Project: A randomized clinical trial: results at 54 months, Circulation, 103, 32, 10.1161/01.CIR.103.1.32 · DOI
  46. Long, 1994, Weight loss in severely obese subjects prevents the progression of impaired glucose tolerance to type II diabetes: A longitudinal interventional study, Diabetes Care, 17, 372, 10.2337/diacare.17.5.372 · DOI
  47. Maggio, 1997, The prevention and treatment of obesity. Application to type 2 diabetes, Diabetes Care, 20, 1744, 10.2337/diacare.20.11.1744 · DOI
  48. National Diabetes Data Group, 1979, Classification and diagnosis of diabetes mellitus and other categories of glucose intolerance, Diabetes, 28, 1039, 10.2337/diab.28.12.1039 · DOI · Paper page
  49. National Heart Lung and Blood Institute, 1998, Clinical guidelines on the identification, evaluation, and treatment of overweight and obesity in adults: The evidence report
  50. Norris, 2004, Efficacy of pharmacotherapy for weight loss in adults with type 2 diabetes mellitus: a meta-analysis, Archives of Internal Medicine, 164, 1395, 10.1001/archinte.164.13.1395 · DOI
  51. O'Meara, 1998, Systematic review of the effectiveness of interventions used in the management of obesity, Journal of Human Nutrition & Dietetics, 11, 203, 10.1046/j.1365-277X.1998.00098.x · DOI
  52. Ornish, 1998, Intensive lifestyle changes for reversal of coronary heart disease, Journal American Medical Association, 280, 2001, 10.1001/jama.280.23.2001 · DOI · Paper page
  53. Perri, 1993, Strategies for improving maintenance of weight loss. Toward a continuous care model of obesity management, Diabetes Care, 16, 200, 10.2337/diacare.16.1.200 · DOI
  54. Rhiel, 1986, The effect of non-normality on the use of the range in estimating the population standard deviation, Journal of Statistics and Computing, 24, 71, 10.1080/00949658608810890 · DOI
  55. Scheen, 2002, Prevention of type 2 diabetes in obese subjects: First results with orlistat in the XENDOS study, Revue Medicale de Liege, 57, 617
  56. Skender, 1996, Comparison of 2-year weight loss trends in behavioral treatments of obesity: diet, exercise and combination interventions, Journal of the American Dietetic Association, 96, 342, 10.1016/S0002-8223(96)00096-X · DOI
  57. Syme, 2004, Social determinants of health: the community as an empowered partner., Preventing Chronic Disease, //www.cdc.gov/p
  58. Tang, 2000, Misleading funnel plot for detection of bias in meta-analysis, Journal of Clinical Epidemiology, 53, 477, 10.1016/S0895-4356(99)00204-8 · DOI · Paper page
  59. The University of York Centre for Reviews and Dissemination, 1997, The prevention and treatment of obesity
  60. Wadden, 1989, Treatment of obesity by very low calorie diet, behavior therapy, and their combination: a five-year perspective, International Journal of Obesity, 13, 39
  61. Wadden, 2000, Behavioral treatment of obesity, Medical Clinics of North America, 84, 441, 10.1016/S0025-7125(05)70230-3 · DOI · Paper page
  62. WHO Expert Committee on Diabetes Mellitus, 1980, World Health Organization Technical Report, World Health Organization Technical Report Series, 646, 1
  63. WHO Expert Committee on Diabetes Mellitus, 1985, World Health Organization Technical Report.
  64. Williamson, 2000, Intentional weight loss and mortality among overweight individuals with diabetes, Diabetes Care, 23, 1499, 10.2337/diacare.23.10.1499 · DOI
  65. Wing, 1985, Behavior change, weight loss, and physiological improvements in type II diabetic patients, Journal of Consulting & Clinical Psychology, 53, 111, 10.1037/0022-006X.53.1.111 · DOI
  66. Wing, 1987, Long-term effects of modest weight loss in type II diabetic patients, Archives of Internal Medicine, 147, 1749, 10.1001/archinte.1987.00370100063012 · DOI · Paper page
  67. Wing, 1991, Effects of a Very-Low-Calorie Diet on Long-Term Glycemic Control in Obese Type 2 Diabetic Subjects, Archives of Internal Medicine, 151, 1334, 10.1001/archinte.1991.00400070100012 · DOI · Paper page
  68. Wing, 1992, Behavioral Treatment of Severe Obesity, American Journal of Clinical Nutrition, 55 (suppl 2), S545, 10.1093/ajcn/55.2.545s · DOI
  69. Wing, 1993, Behavioral treatment of obesity: Its application to type II diabetes, Diabetes Care, 16, 193, 10.2337/diacare.16.1.193 · DOI
  70. Wing, 2001, Strategies for changing eating and exercise behavior, 650
  71. Wing, 2002, Weight loss in the management of type 2 diabetes., 252

Cited by

Sorted by citations

Metadata

Authors
Norris, S. L., Zhang, X., Avenell, A., Gregg, E., Schmid, C. H., & Lau, J.
Affiliations
  • Oregon Health Sciences University; Department of Medical Informatics and Clinical Epidemiology; 3181 SW Sam Jackson Park Road Mail Stop B1CC Portland Oregon USA 97239
  • Center for Disease Control and Prevention; Division of Diabetes Translation; 4770 Buford Highway Mail Stop K-10, Davidson Building Atlanta Georgia USA 30341
  • University of Aberdeen; Health Services Research Unit; Foresterhill Aberdeen UK AB25 2ZD
  • Tufts University School of Medicine; 750 Washington Ave Boston Massachusetts USA MA 02111
  • Tufts Medical Centre; New England Medical Centre/Tufts Evidence-based Practice Center Institute for Clinical Research and Health Policy Studies; 800 Washington Street Box 63 Boston MA USA 02111
Venue
Cochrane Database of Systematic Reviews
Publisher
Wiley
Published
2005-04-20
Volume
2010
Issue
1
ISSN
1465-1858
DOI
10.1002/14651858.cd005270
Cited by
60
References
16
Language
en

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review